GSK once again tops drug ac­ces­si­bil­i­ty rank­ing, with J&J and As­traZeneca close be­hind

Will the pan­dem­ic be a turn­ing point for drug and vac­cine ac­cess around the world? That de­pends on phar­ma’s next steps, ac­cord­ing to the lat­est bi­en­ni­al re­port by the Ac­cess to Med­i­cine Foun­da­tion.

The Bill and Melin­da Gates Foun­da­tion-backed group not­ed “in­dus­try-wide” progress since its last re­port, led by GSK, which kept its first-place ac­ces­si­bil­i­ty rank­ing for the eighth time. How­ev­er, the foun­da­tion al­so re­port­ed that low-in­come coun­tries re­main “wide­ly over­looked,” and many dan­ger­ous dis­eases are go­ing un­ad­dressed.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.